Please check your internet connection and try again.
# Sompraz hp
## Overview
Sompraz hp is a combination medication containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* (*H. pylori*). Pantoprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics.
## Primary Indications
* Eradication of *Helicobacter pylori* (*H. pylori*) infection in patients with peptic ulcer disease.
## Adult Dosing
The typical adult dose is one capsule (containing pantoprazole 40 mg, amoxicillin 500 mg, and clarithromycin 500 mg) twice daily for 7 to 14 days.
* **Dosing Schedule:** Take one capsule in the morning and one capsule in the evening.
* **Duration of Therapy:** 7 to 14 days.
## Pediatric Dosing
There is no established pediatric dosing for Sompraz hp as a fixed-dose combination. Dosing for *H. pylori* eradication in pediatric patients should be individualized based on age, weight, and local guidelines, often using individual components.
## Dose Adjustments
* **Renal Impairment:** Pantoprazole dose adjustment may be necessary in severe renal impairment. Amoxicillin and clarithromycin require dose adjustment in renal impairment. Consult specific drug monographs for detailed recommendations.
* **Hepatic Impairment:** Pantoprazole dose adjustment may be necessary in moderate to severe hepatic impairment. Clarithromycin may require dose adjustment in hepatic impairment.
## Contraindications
* Known hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of hypersensitivity to penicillins, cephalosporins, or macrolides.
* Concomitant use with certain medications (e.g., pimozide, cisapride, ergot alkaloids, midazolam).
* Severe hepatic impairment (for pantoprazole component).
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
## Adverse Effects
Common adverse effects include diarrhea, nausea, abdominal pain, headache, dysgeusia (altered taste), and rash. More serious adverse effects can include *Clostridioides difficile*-associated diarrhea, hypersensitivity reactions, liver enzyme elevations, and QT prolongation (especially with clarithromycin).
## Key Drug Interactions
* **CYP3A4 Inhibitors/Inducers:** Clarithromycin is a moderate inhibitor of CYP3A4, affecting the metabolism of various drugs (e.g., warfarin, some statins, some anticonvulsants, certain anticoagulants).
* **Proton Pump Inhibitors:** Can affect absorption of drugs that require acidic environments (e.g., ketoconazole, itraconazole, certain HIV medications).
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
* **Anticoagulants:** Increased risk of bleeding with concomitant use of warfarin.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Monitor for diarrhea, especially *C. difficile*-associated diarrhea.
* Monitor liver function tests periodically, especially with prolonged use or in patients with pre-existing liver disease.
* Assess for therapeutic efficacy (e.g., symptom resolution, confirmation of *H. pylori* eradication if indicated).
## Clinical Pearls
* Administer Sompraz hp with food to enhance pantoprazole absorption and minimize gastrointestinal upset.
* Ensure patient compliance with the full course of therapy to maximize eradication rates and minimize resistance development.
* If a patient experiences significant side effects, consider discontinuation and alternative *H. pylori* eradication regimens.
* Always verify the specific components and strengths of the fixed-dose combination product available locally, as formulations can vary.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.
